Sedia Biosciences Corporation is a privately held medical device and diagnostics company based in Beaverton, Oregon. They are committed to advancing global access to healthcare through the development of innovative disease surveillance and monitoring tools, accessible point-of-care diagnostic testing, and cost-effective specimen collection devices.
With a focus on infectious diseases, Sedia Biosciences specializes in the development of rapid point-of-care assays that provide cost-effective results from various clinical specimens. They also offer HIV recency assays designed to distinguish recent HIV infections, as well as specimen collection devices that collect, stabilize, and transport specimens for further testing. Additionally, Sedia Biosciences provides genomic services for genomic analysis in human, plant, and animal systems.
Generated from the website